click below
click below
Normal Size Small Size show me how
104 SU25 TG 5 All
PHAR 104 T/G List 5 SUMMER 2025 Ch 19 & 20 ALL
| Generic | Trade | Classification | Indication |
|---|---|---|---|
| potassium chloride | K-Dur, Klor-Con, Micro-K | Electrolyte replacement | hypokalemia |
| calcium carbonate | OsCal, Maalox, Tums | Electrolyte replacement | Antacid, Calcium supplement |
| calcium citrate | Calcitrate, Citracal | Electrolyte replacement | prevent osteoporosis |
| orlistat | Alli, Xenical | Lipase Inhibitor | Obesity |
| phentermine | Adipex, Adipex-P, Lomaira | Sympathomimetic | Obesity |
| phetermine / topiramate | Qsymia | Sympathomimetic | Obesity |
| liraglutide | Saxenda | GLP-1 Agonist | Obesity |
| semaglutide | Wegovy | GLP-1 Agonist | Obesity |
| acetylcysteine | Acetadote | Antidote | APAP OD |
| digoxin immune Fab | DigiFab | Antidote | Digoxin toxicity |
| idarucizumab | Praxbind | Antidote | Pradaxa toxicity |
| naloxone | Narcan | Opioid Antagonist | Opioid OD |
| phytonadione | Mephyton | Vitamin K | Warfarin toxicity |
| flumazenil | Romazicon | Benzodiazepine Antagonist | Benzo OD |
| carboplatin | Paraplatin | Alkylating Agent | Brst CA, Lung CA |
| cisplatin | Platinol | Alkylating Agent | Bladder CA, Ovarian CA |
| cyclophosphamide | Cytoxan | Alkylating Agent | Brst CA, Leukemia, Autoimmune disorders |
| ifosfamide | Ifex | Alkylating Agent | Lymphoma |
| fluorouracil | Adrucil | Antimetabolite | Brst CA, Colon CA |
| methotrexate | Trexall, Xatmep | Antimetabolite | Leukemia, Lymphoma, RA, SLE |
| doxorubicin | Adriamycin | Topoisomerase Inhibitor | Brst CA, Leukemia |
| topotecan | Hycamtin | Topoisomerase Inhibitor | Lung CA, Ovarian CA |
| docetaxel | Taxotere | Taxane | Brst CA, Lung CA |
| paclitaxel | Taxol | Taxane | Brst CA, Lung CA |
| vinblastine | Velban | Vinca Alkaloid | Lymphoma |
| tamoxifen | Nolvadex | SERM | Brst CA |
| anastrozole | Arimidex | Antiestrogen | Brst CA |
| palbociclib | Ibranse | CDK 4/6 Inhibitor | Brst CA |
| gefitinib | Iressa | TK Inhibitor | Lung CA |
| ibrutinib | Imbruvica | TK Inhibitor | Leukemia |